^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
SOPHiA DDM™ Solid Tumor Plus Solution

Type:
Laboratory Developed Test
Related tests:
Evidence

News

5ms
Real-World Experience With the Angio-Seal Closure Device: Insights From Manufacturer and User Facility Device Experience Database. (PubMed, J Endovasc Ther)
Our study highlights important safety events encountered in real-world practice with Angio-Seal closure device. The MAUDE database captures real-world device malfunctions not typically appreciated in conventional clinical trials. Our study provides valuable insight for clinician-users on anticipating and managing the most common device malfunctions. Additionally, our data provide feedback for manufactures to optimize product design and direct manufacturer user training to improve safety. Finally, we hope that the study promotes system-level strategies that foster reporting of safety events and undertaking of root cause analysis.
Journal • Real-world evidence • Real-world
|
SOPHiA DDM™ Solid Tumor Plus Solution
11ms
Evaluating Gene Fusions in Solid Tumors by Next- Generation Sequencing: A Tertiary Centre Experience (AMP Europe 2023)
"Gene fusions represent crucial targets in the context of precision medicine. NGS testing for fusion detection not only allows analysis of multiple targets but also saves time and material. The identification of novel fusions in this study also highlights the potential for future therapeutic targets."
BRAF (B-raf proto-oncogene) • ALK (Anaplastic lymphoma kinase) • MSI (Microsatellite instability) • ROS1 (Proto-Oncogene Tyrosine-Protein Kinase ROS) • NTRK1 (Neurotrophic tyrosine kinase, receptor, type 1) • NTRK3 (Neurotrophic tyrosine kinase, receptor, type 3) • FGFR3 (Fibroblast growth factor receptor 3) • FGFR1 (Fibroblast growth factor receptor 1) • TACC3 (Transforming acidic coiled-coil containing protein 3) • ETV6 (ETS Variant Transcription Factor 6) • LMNA (Lamin A/C) • DCTN1 (Dynactin Subunit 1) • AGK (Acylglycerol Kinase) • SDC4 (Syndecan 4) • NTRK (Neurotrophic receptor tyrosine kinase)
|
EGFR mutation • NTRK1 fusion • MET exon 14 mutation • ROS1 positive • EGFRvIII mutation • FGFR1 fusion • FGFR3 fusion • LMNA-NTRK1 fusion • SDC4-ROS1 fusion • NTRK fusion
|
SOPHiA DDM™ Solid Tumor Plus Solution